reports
- ING Helpdesk
- Guy Sips
- Livio Luyten
- Michiel Declercq
- Thibault Leneeuw
- Wim Lewi
- Michiel Declercq
JDE Peets CMD: Launches new strategy and financial ambitions
Today, JDE Peet's will hold a CMD in Amsterdam where it will unveil its “Reignite the Amazing” strategy. The new strategy focuses on 3 big bets, including Peet's, L'Or and 10 local icons led by Jacobs. Additionally, the group is targeting € 500m in productivity savings, of which 50% is expected to be achieved by 2027. The group further also disclosed new LT targets, including an Adj. EBIT CAGR of 3-4% in FY26/27, 4-5% in FY28/29 and 5-8% between FY30/32. This compares to a mid-single digit organ...
- Jacob Mekhael
- Livio Luyten
- Michiel Declercq
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Jacob Mekhael
argenx FDA FAERS reporting flags Vyvgart Hytrulo in routine update
Yesterday during trading hours, the FDA flagged worsening of CIDP with Vyvgart Hytrulo as a new safety signal via a routine update to the FDA adverse event reporting system (FAERS), which sent the argenx' stock down approx. 8%. While CIDP worsening was also reported in patients switching between treatments from IVig to SCig in the PATH study, physicians navigate treatment switches carefully, and based on argenx' own post-marketing surveillance,
JDE Peet’s unveils brand-led strategy to accelerate profitable growth ...
JDE Peet’s unveils brand-led strategy to accelerate profitable growth and unlock value PRESS RELEASEAmsterdam, July 1, 2025 Strategy is focussed on simplifying and reinvesting in highest-potential growth opportunitiesEUR 500M net productivity savings targeted, with more than 50% of savings achieved by the end of 2027Savings to be equally split between reinvestments for growth and profit expansionSets new, accelerating medium-term financial targetsImprove net leverage target to 2xDisciplined capital allocation aligned with strategy At its Capital Markets Day today in Amsterdam, JDE Peet’s ...
JDE Peet’s share buyback periodic update June 30, 2025
JDE Peet’s share buyback periodic update June 30, 2025 PRESS RELEASEAmsterdam, June 30, 2025 JDE Peet’s (EURONEXT: JDEP), the world’s leading pure-play coffee and tea company, today announced that it has repurchased 15,429 shares in the period from June 23, 2025 up to and including June 27, 2025. The shares were repurchased at an average price of EUR 24.10 per share for a total consideration of EUR 0.4 million. These repurchases were made as part of the EUR 250 million share buyback programme . The total number of shares repurchased under this programme to date is 3,773,550 ordinary sha...
- Jacob Mekhael
argenx FIRST LOOK: ARGX-119 Ph1b shows POC in CMS, Ph3 in preparation
argenx announced its plan to advance the clinical development of ARGX-119 (muscle-specific kinase [MuSK] agonist antibody) to a registrational study in patients with congenital myasthenic syndromes (CMS) following the analysis of topline data from the phase 1b study, which showed consistent improvements through the 12-week study across multiple efficacy scores. This marks the 3rd candidate to advance to phase 3 from argenx' internal pipeline, which in our view supports the company's future growt...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Thomas Couvreur
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthe...
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes Phase 1b study supports proof-of-concept in DOK7 congenital myasthenic syndromes Decision informed by favorable safety profile and consistent functional improvement over time across multiple efficacy measures Advancing ARGX-119 further validates strong track record of Immunology Innovation Program (IIP), argenx's collaborative discovery model June 30, 2025, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of p...
- Olfa Taamallah
- Yan Derocles
ENGI ENGIE SA.
BNP BNP PARIBAS SA CLASS A
MTX MTU AERO ENGINES AG
HO THALES SA
FGA FIGEAC AERO SA
MUV2 MUNICH REINSURANCE COMPANY
RHM RHEINMETALL AG
EL ESSILORLUXOTTICA SA
FII LISI SA
GOE GROUPE GORGE SA
G ASSICURAZIONI GENERALI S.P.A.
SCHP SCHINDLER HOLDING AG PREF
SAF SAFRAN S.A.
AIR AIRBUS SE
01913 PRADA S.P.A.
BA. BAE SYSTEMS PLC
AMS AMADEUS IT GROUP SA CLASS A
FACC FACC AG
LDO LEONARDO SPA
SIE SIEMENS AG
HAG HENSOLDT AG
AERO MONTANA AEROSPACE AG
AM DASSAULT AVIATION
LAT LATECOERE
R3NK RENK GROUP AG
EXENS EXOSENS
- Olfa Taamallah
- Yan Derocles
ENGI ENGIE SA.
BNP BNP PARIBAS SA CLASS A
MTX MTU AERO ENGINES AG
HO THALES SA
FGA FIGEAC AERO SA
MUV2 MUNICH REINSURANCE COMPANY
RHM RHEINMETALL AG
EL ESSILORLUXOTTICA SA
FII LISI SA
GOE GROUPE GORGE SA
G ASSICURAZIONI GENERALI S.P.A.
SCHP SCHINDLER HOLDING AG PREF
SAF SAFRAN S.A.
AIR AIRBUS SE
01913 PRADA S.P.A.
BA. BAE SYSTEMS PLC
AMS AMADEUS IT GROUP SA CLASS A
FACC FACC AG
LDO LEONARDO SPA
SIE SIEMENS AG
HAG HENSOLDT AG
AERO MONTANA AEROSPACE AG
AM DASSAULT AVIATION
LAT LATECOERE
R3NK RENK GROUP AG
EXENS EXOSENS
- Nicolas David
- Yan Derocles
- Nicolas David
- Yan Derocles
JDE Peet’s share buyback periodic update June 23, 2025
JDE Peet’s share buyback periodic update June 23, 2025 PRESS RELEASE Amsterdam, June 23, 2025 JDE Peet’s (EURONEXT: JDEP), the world’s leading pure-play coffee and tea company, today announced that it has repurchased 29,236 shares in the period from June 16, 2025 up to and including June 20, 2025. The shares were repurchased at an average price of EUR 23.34 per share for a total consideration of EUR 0.7 million. These repurchases were made as part of the EUR 250 million share buyback programme . The total number of shares repurchased under this programme to date is 3,758,121 ordinary s...
- Jacob Mekhael
argenx European Commission approves Vyvgart SC in CIDP
argenx announced that the European Commission (EC) approved Vyvgart SC for the treatment of adults with progressive or relapsing active CIDP after prior treatment with corticosteroids or immunoglobulins, which comes in line with expectations following the positive CHMP opinion issued in April 2025. We anticipate a steady country by country EU launch, and continue to expect the US to remain the main driver for Vyvgart's commercial launch. We currently estimate approx. $ 1.1bn in peak sales for CI...
- Hilde Van Boxstael
- Jacob Mekhael
- Wim Lewi
argenx Announces European Commission Approval of VYVGART Subcutaneous ...
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDPApproval based on ADHERE clinical trial, the largest study of CIDP patients to dateFirst novel mechanism of action for CIDP treatment in more than 30 years June 20, 2025, 7:00 PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the liv...
- Research Department
IBERIAN DAILY 17 JUNE (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: AEDAS HOMES, AMADEUS, IBERDROLA, NEINOR HOMES. The market recovers European stock markets rallied, driven by the possibility of a de-escalation of the situation in the Middle East. In this regard, Iran would be trying to stop the hostilities through the US in exchange for resuming talks on the nuclear agreement. In the STOXX 600, the best-performing sectors were Travel & Leisure and Banks, whereas defensive sectors like Pharma and Food suffered the biggest drops. On the macro side...
- Research Department
INFORME DIARIO 17 JUNIO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: AEDAS, AMADEUS, IBERDROLA, NEINOR HOMES. EUROPA: AXA, KERING. El mercado se recupera Rebote en las bolsas europeas, impulsadas por la posibilidad de ver cierta desescalada en la situación de Oriente Medio. En este sentido, Irán estaría intentando detener las hostilidades a través de EE.UU. a cambio de reanudar las conversaciones sobre el pacto nuclear. En el STOXX 600 los mejores sectores fueron Viajes&Ocio y Bancos, mientras que defensivos como Fa...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.